Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Kisspeptin-10 structure

Kisspeptin-10

Other
Phase 2 Research
50%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 100 mcg
Range 50 - 500 mcg

Pharmacokinetics

Half-Life 4 min
Onset 1 min
Peak 5 min
Duration 30 min
Bioavailability 90%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intravenous
Injection Sites Abdomen
Needle Gauge 29-31G
Syringe Type Insulin
Timing Morning

Reconstitution

Diluent Bacteriostatic Water
Volume 1 mL
Stability 7 days refrigerated
Vial Sizes 1 mg

Special Instructions

Very short half-life (4 min). Research compound for fertility. IV administration used in clinical research.